Thyrotropin releasing hormone in therapy of shock and as a centr

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2601125TR, A61K 3724, C07C10352, C07G 700

Patent

active

044263783

ABSTRACT:
The therapeutic use of thyrotropin releasing hormone (TRH), its analogs aor metabolites in the treatment of circulatory shock and/or central nervous system (CNS) ischemic damage is disclosed. Additional evidence of the utility of TRH as a CNS stimulant is revealed.

REFERENCES:
patent: 3746697 (1973-07-01), Folkers et al.
patent: 3757003 (1973-09-01), Folkers et al.
patent: 3912705 (1975-10-01), Fujino et al.
patent: 3931139 (1976-06-01), Wissmann et al.
patent: 3959248 (1976-05-01), Veber et al.
patent: 4066749 (1978-01-01), Veber et al.
patent: 4100152 (1978-07-01), Fujino et al.
patent: 4112073 (1978-09-01), Ono
patent: 4113713 (1978-09-01), Schlatter et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Thyrotropin releasing hormone in therapy of shock and as a centr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thyrotropin releasing hormone in therapy of shock and as a centr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thyrotropin releasing hormone in therapy of shock and as a centr will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-700429

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.